ID   BL-69
AC   CVCL_M560
SY   BL69; BL 69; IARC/BL69; IARC/BL 69; IARC-BL69; IARC BL69; IARC BL 69
DR   Wikidata; Q54797240
RX   PubMed=3934070;
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Characteristics: EBV-negative.
CC   Derived from sampling site: Bone marrow.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens
OI   CVCL_C154 ! BL-63
OI   CVCL_VQ34 ! BL-68
OI   CVCL_1088 ! BL-70
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-07-20; Version: 8
//
RX   PubMed=3934070;
RA   Lenoir G.M., Vuillaume M., Bonnardel C.;
RT   "The use of lymphomatous and lymphoblastoid cell lines in the study of
RT   Burkitt's lymphoma.";
RL   IARC Sci. Publ. 60:309-318(1985).
//
RX   PubMed=6090749; DOI=10.1093/jnci/73.4.835;
RA   Philip I., Philip T., Favrot M.C., Vuillaume M., Fontaniere B.,
RA   Chamard D., Lenoir G.M.;
RT   "Establishment of lymphomatous cell lines from bone marrow samples
RT   from patients with Burkitt's lymphoma.";
RL   J. Natl. Cancer Inst. 73:835-840(1984).
//